CLINICAL_TRIALS trial_result · 2013-09-25

Clinical Trial Update: Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH) [Phase 3]

Phase 3 study of once-daily tadalafil in Asian men with benign prostatic hyperplasia has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Benign Prostatic Hyperplasia | Phase 3 | Status: COMPLETED | Results posted: 2013-09-25